Background: Until recently, metronidazole was the first-line treatment for Clostridioides difficile infection and it is still commonly used. Though resistance has been reported due to the plasmid pCD-METRO, this does not explain all cases.
Objectives: To identify factors that contribute to plasmid-independent metronidazole resistance of C. difficile.
Methods: Here, we investigate resistance to metronidazole in a collection of clinical isolates of C. difficile using a combination of antimicrobial susceptibility testing on different solid agar media and WGS of selected isolates.
Results: We find that nearly all isolates demonstrate a haem-dependent increase in the MIC of metronidazole, which in some cases leads to isolates qualifying as resistant (MIC >2 mg/L). Moreover, we find an SNP in the haem-responsive gene hsmA, which defines a metronidazole-resistant lineage of PCR ribotype 010/MLST ST15 isolates that also includes pCD-METRO-containing strains.
Conclusions: Our data demonstrate that haem is crucial for medium-dependent metronidazole resistance in C. difficile.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212768 | PMC |
http://dx.doi.org/10.1093/jac/dkab097 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!